Patients Discontinuing Weight-Loss Medications Regain Pounds at a Quadrupled Rate Than Those on Conventional Diets

New research reveals that people who come off new weight-loss injections like semaglutide or tirzepatide can put back on reduced body mass much more quickly than those who stop conventional lifestyle programs.

Published data in a major health publication shows that while overweight people often shed a large proportion of their total mass while using the jabs, the weight comes back at an estimated rate of nearly a kilo each month upon discontinuation.

"People using these treatments need to be informed of the potential of rapid rebound weight gain when the medication is stopped," warns lead investigator Dr. Susan Jebb.

This pace of recovery means a reversion to starting weight within about 18 months.

Weighing Treatments

The study, which reviewed 37 of studies involving over 9,000 of participants, contrasted the results of the injectable medications with conventional dieting.

Scientists point out that individuals who lose weight through diet and exercise typically experience a slower weight regain—approximately 100 grams monthly—after stopping.

Explaining the Rapid Regain

Experts suggest the mechanism of the injections is key to understanding the amplified rebound.

These medications imitate a natural hormone called glucagon-like peptide-1, which moderates feelings of fullness.

"Artificially providing GLP-1 levels several times higher than the body's typical production might result in the body to generate a reduced amount of its endogenous GLP-1, and may also lessen responsiveness to its actions," noted Dr. Adam Collins, a nutrition researcher.

"Stopping of this hormone supplement results in appetite is unsuppressed, making overeating a significant risk."

An Ongoing Disease?

The NHS advise the jabs for individuals with obesity-related health risks, alongside prescribed lifestyle changes.

Many experts argue that, given the significant potential of weight regain, the therapy might need to be life-long.

This view is supported by pharmaceutical companies, who note that the findings "emphasize the long-term character of obesity," comparing it to managing diseases like diabetes.

User Experiences

People who have stopped the jabs report a intense return of cravings.

"I experienced a trigger that goes on and you become starving," recalled one woman.

The struggle is worsened if patients have not developed sustainable lifestyle or habit changes during treatment.

Significant Adoption

Figures indicate that millions of adults in the UK have used these injections in the past year, with desire remaining high.

• Use is greater among women than men.
• The middle-aged demographic shows the highest level of interest.
• Many access the medications through private healthcare rather than public health services.

In conclusion, experts stress that while these medications are effective tools for weight loss, they are not a magic fix and lasting health benefits hinges on ongoing lifestyle support.